Form 4: AbbVie's Chairman and CEO, Richard Gonzalez, Reports Changes in Beneficial Ownership
SEC Filing
Richard Gonzalez, Chairman and CEO of AbbVie, filed a Form 4 detailing changes in his beneficial ownership of the company's stock due to gift transactions.
Summary
- On February 27, 2024, Richard A. Gonzalez, Chairman and CEO of AbbVie Inc., reported changes in his beneficial ownership of AbbVie common stock.
- The filing indicates that Mr. Gonzalez disposed of 1,670 shares and 2,525 shares of common stock through gift transactions.
- Following these transactions, Mr. Gonzalez beneficially owns 767,964 shares of AbbVie common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall impact is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date of the transactions (gift of shares). |
| 02/29/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.